It's been an up and down roller coaster of news for INC Research. A couple of weeks ago, it announced the impending closure of its Old Lyme, CT, facility, only to announce later that month that it secured a three-year FSP deal with Japanese pharma giant Astellas. Now, INC is facing another facility closure. Its clinical study unit in Morgantown, WV, will be shut down, according to a story by The State Journal.
The Morgantown facility, which handles Phase I work for INC, will close sometime during the third quarter of the year, resulting in the loss of around 30 jobs. On top of that, 66 other positions will be lost when INC closes its Old Lyme facility this summer. Both the Morgantown and Old Lyme units were acquired when INC purchased Kendle International last year.
But while the Old Lyme closure will be due to the lack of clinical opportunities in Connecticut, the Morgantown closure can be contributed to a desire to focus more on early-phase development, according to a statement INC sent to The State Journal. "Following a review of strategic priorities, INC Research has decided to refocus our presence in the Early Phase market to meet a broader range of Phase I needs for our customers," the statement read.
- check out the story from The State Journal
Related Stories:
INC Research axes staffers, closes Connecticut lab
INC snags Kendle's global CRO operations for $232M in cash
INC Research and Astellas expand alliance